Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | PLA2G1B | P04054 | 3/20 | 0.38 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.38 |
| ▸ | MMP2 | P08253 | 2/20 | 0.38 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | ANPEP | P15144 | 1/20 | 0.38 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.38 |
| ▸ | RAD52 | P43351 | 1/20 | 0.38 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.36 |
| ▸ | KDM5A | P29375 | 2/20 | 0.36 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.36 |
| ▸ | FAAH | O00519 | 2/20 | 0.36 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12515903 | 1.00 | GPR84 (0.40) | GPR84FFAR4FFAR1PLA2G1BPSMD14 | |
| SCHEMBL12515783 | 1.00 | GPR84 (0.40) | GPR84FFAR4FFAR1PLA2G1BPSMD14 | |
| SCHEMBL21554930 | 0.90 | GPR84 (0.42) | GPR84FFAR4FFAR1PLA2G1BPSMD14 | |
| SCHEMBL25955602 | 0.90 | GPR84 (0.42) | GPR84FFAR4FFAR1PLA2G1BPSMD14 | |
| SCHEMBL24045753 | 0.90 | GPR84 (0.42) | GPR84FFAR4FFAR1PLA2G1BPSMD14 | |
| SCHEMBL13964577 | 0.90 | L3MBTL1 (0.37) | GPR84FFAR4FFAR1PLA2G1BPSMD14 | |
| SCHEMBL13964576 | 0.90 | L3MBTL1 (0.37) | GPR84FFAR4FFAR1PLA2G1BPSMD14 | |
| SCHEMBL4602473 | 0.87 | DNM1 (0.45) | GPR84FFAR4FFAR1PLA2G1BPSMD14 | |
| SCHEMBL4601959 | 0.87 | DNM1 (0.45) | GPR84FFAR4FFAR1PLA2G1BPSMD14 | |
| SCHEMBL4602087 | 0.87 | DNM1 (0.45) | GPR84FFAR4FFAR1PLA2G1BPSMD14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120289584-A1 | COMPOSITIONS COMPRISING CATIONIC AMPHIPHILES AND COLIPIDS FOR DELIVERING THERAPEUTIC MOLECULES | AGAVE PHARMA, INCORPORATED (US) | 2012-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120289584-A1 | COMPOSITIONS COMPRISING CATIONIC AMPHIPHILES AND COLIPIDS FOR DELIVERING THERAPEUTIC MOLECULES | ANXA4, ANXA6, RNASE1 | GPR84 1196/4885FFAR4 3728/4885FFAR1 4259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.